中芯國際(00981.HK)斥資497億人幣建設晶圓廠 首期2024年完工
內媒報道指,中芯國際(00981.HK)與北京亦莊國際合資的中芯京城集成電路製造公司,目前正建設中芯京城12英吋集成電路晶圓及集成電路封裝項目的第一期工程,計劃於2024年完工,建成後每月12英吋晶圓產能將達到約10萬片。
項目分兩期建設,總投資約497億元人民幣,一期項目建設規模約24萬平方米,包含FAB3P1生產廠房及配套建築、構築物等,目前正處於打基礎樁階段,預計2月底完成。
中芯與北京亦莊、國家集成電路產業投資基金二期股份於去年12月成立中芯京城,註冊資本為50億美元,其中中芯持股51%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.